Finding New Genes for Early-Onset Glaucoma
Using Forward Genetics to Explore the Genetics and Mechanisms of Early Onset Glaucoma
This research aims to discover new genes and pathways that cause early-onset glaucoma, a condition that can lead to blindness.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11115690 on NIH RePORTER |
What this research studies
Many cases of early-onset glaucoma have a genetic cause, but we only know a few of the genes involved. This project uses a special approach to find new genes and understand the biological processes that lead to this blinding eye disease. By studying these genes, we hope to gain a better understanding of how early-onset glaucoma develops. This knowledge could eventually lead to improved ways to screen for the condition and new treatment options for patients.
Who could benefit from this research
Good fit: This foundational research does not involve direct patient participation but aims to benefit individuals with early-onset glaucoma in the future.
Not a fit: Patients without early-onset glaucoma or those seeking immediate treatment options would not directly benefit from this basic science research.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of early-onset glaucoma, potentially improving early detection and opening doors for new treatments.
How similar studies have performed: The 'Forward Genetics' approach used in this project is a robust and unbiased strategy that has been successfully applied in other areas of genetic discovery.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Ufret-Vincenty, Rafael — Ut Southwestern Medical Center
- Study coordinator: Ufret-Vincenty, Rafael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.